What is Osso VR?
Founded in 2016 and headquartered in Palo Alto, California, Osso VR provides a sophisticated surgical training platform that utilizes virtual reality to deliver realistic, hand-based interactions. The platform is engineered to support surgeons, hospital staff, and medical device sales teams across varying levels of expertise. By creating an immersive environment that mimics high-stakes operating room scenarios, Osso VR addresses the growing demand for scalable, objective, and repeatable training solutions in the healthcare industry. Its market position is defined by its ability to bridge the gap between traditional didactic learning and hands-on clinical experience, effectively reducing the learning curve for new medical technologies.
How much funding has Osso VR raised?
Osso VR has raised a total of $107.3M across 4 funding rounds:
Series A
$14M
Series B
$27M
Series C
$66M
Other Financing Round
$250K
Series B (2021): $27M with participation from Scrum Ventures, GSR Ventures, Kaiser Permanente Ventures, OCA Ventures, and SignalFire
Series A (2021): $14M led by Kaiser Permanente
Series C (2022): $66M supported by Oak HC/FT
Other Financing Round (2025): $250K featuring Blume Ventures
Key Investors in Osso VR
Oak HC/FT
Oak HC/FT is a premier venture growth-equity fund specializing in Healthcare Information and Services and Financial Services Technology, providing strategic counsel and board-level participation to transformative companies.
Kaiser Permanente Ventures
Kaiser Permanente Ventures is a national leader in strategic healthcare investing, focusing on advancing innovation that provides clear value for patients, providers, and healthcare delivery systems.
SignalFire
SignalFire is a venture capital firm that utilizes a proprietary AI platform, Beacon AI, to provide data-driven insights and expert support to early-stage teams across the healthtech and enterprise sectors.
What's next for Osso VR?
With this major strategic investment, Osso VR is well-positioned to accelerate its product development roadmap and expand its footprint within global healthcare systems. The company is expected to focus on deepening its library of procedural simulations and enhancing the data analytics capabilities of its platform, which provide objective performance metrics for surgical teams. As the healthcare sector increasingly prioritizes digital health innovation to improve patient outcomes and operational efficiency, Osso VR's focus on high-fidelity simulation will likely remain a cornerstone of its long-term growth strategy. The firm will likely leverage this capital to strengthen its enterprise-level partnerships and further integrate its technology into the standard curriculum of teaching hospitals and medical device manufacturers worldwide.
See full Osso VR company page
